BlossomHill Therapeutics Inc.
BLSM | NASDAQ
$26.94
+$0.14 (+0.52%)
Sep 22, 2026, 11:32 AM ET · Market open
TTM Period Ending | Q1 2026 Mar 30, 2026 | Q1 2025 Mar 30, 2025 |
|---|---|---|
Net Income | -21.01M | -10.48M |
Depreciation & Amortization | 125K | 85K |
Stock-Based Compensation | 323K | 231K |
Other Working Capital | -3.77M | -1.65M |
Other Non-Cash Items | 325K | 179K |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -705K | -996K |
Operating Cash Flow | -20.94M | -10.98M |
Capital Expenditures | -13K | -402K |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -13K | -402K |
Debt Repayment | n/a | n/a |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | 274K | 39K |
Financial Cash Flow | 274K | 39K |
Net Cash Flow | -20.68M | -11.34M |
Free Cash Flow | -20.95M | -11.38M |
Adj. Free Cash Flow | -21.28M | -11.61M |
Maintenance CapEx | n/a | n/a |
Growth CapEx | n/a | n/a |
Owner Earnings | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BLSM